- Home
- COSM vs AYTU Comparison
COSM vs AYTU Comparison
Compare COSM & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- AYTU
- Stock Information
- Founded
- COSM 2009
- AYTU N/A
- Country
- COSM Greece
- AYTU United States
- Employees
- COSM N/A
- AYTU N/A
- Industry
- COSM Other Pharmaceuticals
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- COSM Health Care
- AYTU Health Care
- Exchange
- COSM Nasdaq
- AYTU Nasdaq
- Market Cap
- COSM 8.2M
- AYTU 8.3M
- IPO Year
- COSM 2013
- AYTU N/A
- Fundamental
- Price
- COSM $0.40
- AYTU $1.05
- Analyst Decision
- COSM
- AYTU
- Analyst Count
- COSM 0
- AYTU 0
- Target Price
- COSM N/A
- AYTU N/A
- AVG Volume (30 Days)
- COSM 334.1K
- AYTU 31.3K
- Earning Date
- COSM 04-16-2025
- AYTU 05-14-2025
- Dividend Yield
- COSM N/A
- AYTU N/A
- EPS Growth
- COSM N/A
- AYTU N/A
- EPS
- COSM N/A
- AYTU N/A
- Revenue
- COSM $54,426,402.00
- AYTU $77,232,000.00
- Revenue This Year
- COSM $28.14
- AYTU N/A
- Revenue Next Year
- COSM N/A
- AYTU $8.14
- P/E Ratio
- COSM N/A
- AYTU N/A
- Revenue Growth
- COSM 1.97
- AYTU N/A
- 52 Week Low
- COSM $0.28
- AYTU $0.95
- 52 Week High
- COSM $1.58
- AYTU $3.45
- Technical
- Relative Strength Index (RSI)
- COSM 48.76
- AYTU 41.21
- Support Level
- COSM $0.28
- AYTU $0.99
- Resistance Level
- COSM $0.39
- AYTU $1.10
- Average True Range (ATR)
- COSM 0.05
- AYTU 0.08
- MACD
- COSM 0.01
- AYTU 0.01
- Stochastic Oscillator
- COSM 71.45
- AYTU 55.56
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.